| |
Antiviral Therapy for Chronic Hepatitis B Reduces the Incidence of Hepatocellular Carcinoma Regardless of Cirrhosis Status: Analysis with Adjustment for REACH-B Risk Score
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Hwai-I Yang, PhD
Derek Lin1; Hwai-I Yang2,3; Nghia H. Nguyen4,5; Joseph Hoang4; Yoona Kim4; Vinh Vu4; An Le4; Kevin Chaung4,6; Vincent Nguyen4,6; Huy Trinh7; Jiayi Li8; Jian Zhang9; Ann Hsing10,11,12; Chien-Jen Chen2,13; Mindie H. Nguyen
1 Department of Internal Medicine, Stanford University Medical Center, USA
2 Genomics Research Center, Academia Sinica, Taiwan
3 Institute of Clinical Medicine, National Yang-Ming University, Taiwan
4 Division of Gastroenterology and Hepatology, Stanford University Medical Center, USA
5 Department of Internal Medicine, University of California San Diego, USA
6 Pacific Health Foundation, USA
7 San Jose Gastroenterology, USA
8 Palo Alto Medical Foundation, Mountain View Division, USA
9 Chinese Hospital, San Francisco, USA
10 Cancer Prevention Institute of California, USA
11 Stanford Cancer Institute, Stanford School of Medicine, USA
12 Health Research and Policy Department, Stanford School of Medicine, USA
13 Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taiwan
|
|
| |
| |
|
|
|
